Xilio Therapeutics, Inc. (XLO) Earnings
|
Expand Research on XLO
| Next EPS Date | 11/5/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -69.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/26  |
Q326 | N/A | -$0.92 | N/A | N/A | $5.74M | N/A | N/A | N/A | ||
| 8/12/26 | Q226 | -$0.33 | -$0.58 | +$0.25 | $18.7M | $7.27M | N/A |  | | Details | |
| 5/7/26 |
Q126 | N/A | -$0.07 | N/A | N/A | $10.9M | N/A | N/A | N/A | ||
| 3/10/26 |
Q425 | N/A | -$0.07 | N/A | N/A | $10.9M | N/A | N/A | N/A | ||
| 3/4/26 |
Q425 | N/A | -$0.07 | N/A | N/A | $10.9M | N/A | N/A | N/A | ||
| 3/9/26 |
Q425 | N/A | -$0.07 | N/A | N/A | $10.9M | N/A | N/A | N/A | ||
| 3/6/26 |
Q425 | N/A | -$0.07 | N/A | N/A | $10.9M | N/A | N/A | N/A | ||
| 3/11/26 |
Q425 | N/A | -$0.07 | N/A | N/A | $10.9M | N/A | N/A | N/A |
